Amgen vs. Sanofi, and patent enablement
In Amgen vs. Sanofi, SCOTUS asks if breakthrough drugs require an impossibly high 35 USC 112(a) enablement test for patent protection. Many … Read more
Stephen E. Zweig, PhD JD, Patent Attorney
In Amgen vs. Sanofi, SCOTUS asks if breakthrough drugs require an impossibly high 35 USC 112(a) enablement test for patent protection. Many … Read more
Is your proposed trademark logo infringing or not? The WIPO Artificial Intelligence (AI) trademark search engine (trademark checker) can provide helpful insight. … Read more
Method claims are different from system, device, or apparatus claims. Method claims are easier to get, but system claims are easier to … Read more
Means plus function claims, described in 35 USC 112(f), are a tricky area of patent law. Unlike more commonly used “structural” claims, … Read more
Optimize your intellectual property strategy by using a combination of patents, trademarks, copyrights, and trade secrets. In theory, the different categories of … Read more
Utility patents are the best way to protect most inventions. But to get one, you have to convince a USPTO examiner that your … Read more